Key facts
- This page summarizes Amit Sachdev's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2023, 15:56.
Amit Sachdev - 01 Feb 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP, Chief Patient Officer
- Issuer ticker
- VRTX
- Reported as of
- 01 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2023, 15:56:38 UTC
- Prior SEC filing
- 11 Mar 2022
- Next SEC filing
- 14 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amit Sachdev filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 03 Feb 2023.
Change
- Previous filing in this sequence was filed on 11 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,672
- Change %
- -13%
- Price
- $0.000000
- Shares after
- 11,052
- Date
- 17 May 2022
- Ownership
- Held in Trust
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,324
- Change %
- +19%
- Price
- $0.000000
- Shares after
- 63,676
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +8,210
- Change %
- +13%
- Price
- $0.000000
- Shares after
- 71,886
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,866
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 79,752
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F3
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 882
- Date
- 01 Feb 2023
- Ownership
- 401(k)
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 8,861
- Date
- 01 Feb 2023
- Ownership
- Held in Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest on 02/13/2023.
Footnote F2
Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest in installments beginning on 02/24/2023.
Footnote F3
Restricted stock unit award that vests in installments beginning on 02/10/2024.